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A B S T R A C T
The aim of the study was to establish the seroprevalence of herpes simplex virus type 2 (HSV-2) among sexually active
adults from East Croatia and to evaluate its correlates with demographic and behavioural risk factors. This cross-sec-
tional study was conducted from the 1st June until the 30th September 2005 at the Department of Transfusion Medicine,
Osijek University Hospital Center. The study included 423 blood donors composed of 366 (86.5%) men and 57 (13.5%)
women. Demographic data and data on the risky sexual behaviour during the lifetime were collected with usage of an
anonymous questionnaire consisting of 15 questions. Western blot testing revealed that 3.3% (14/423) subjects were posi-
tive for the presence of IgG antibodies to herpes simplex virus 2, i.e. 10 (2.7%) men and 4 (7.0%) women. A higher HSV-2
seroprevalence was associated with female sex, older age, marital status (with single subjects been under the greater
risk), irregular condom use on sexual intercourses with new partners and with higher number (five or more) of sexual
partners during lifetime. Among determined risk factors in the study population, only the connection between the HSV-2
positivity and the older age was statistically significant. The study has showed that the demographic rather than the be-
havioural risk factors are associated with higher prevalence of HSV-2 antibodies in the observed population.
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Introduction
Herpes simplex virus type 2 (HSV-2) infections are
considered to be almost always sexually transmitted1–3,
and it has been established that the presence of antibod-
ies to HSV-2 correlates highly with past sexual behaviour
of a person and/or his or her sexual partners4. Exact
proof for the fact that HSV-2 is almost exclusively sexu-
ally transmitted (with the exception of rare perinatal acqui-
sition) is data from the surveys investigating the seropre-
valence of HSV-2 among the subjects from different sub-
population groups. These had showed how seroprevalen-
ce of antibodies to HSV-2 in sera of the subjects that had
never been sexually active is negligible or equal to zero5.
In recent years, HSV glycoprotein (gG) was identified
as a viral protein that specifies predominantly type-spe-
cific epitopes, and measurement of antibodies directed
against HSV-2 glycoprotein G (gG2) is now possible by
the use of commercially available glycoprotein G2-based
enzyme immunoassays. The use of those has largely sim-
plified the evaluation of seroprevalence of HSV-2 in epide-
miological studies4,6,7. Besides that, there is also a possi-
bility of using the Western blot assay that has more than
98% sensitivity and specificity for distinguishing between
specific herpes simplex type 1 (HSV-1) and herpes sim-
plex type 2 (HSV-2) antibodies4,8,9. Western blot is consid-
ered to be the traditional »gold standard« for differenti-
ating between type 1 and type 2 antibodies10–13, although
its use is limited to only few research laboratories due to
its complexity and price12. The most important thing is,
that today, by using the combination of these two meth-
ods (type specific enzyme immunoassays and Western
blot assay) it is possible to determine ones contact with
HSV-2 with exact certainty.
Experts consider that almost two decades world is fac-
ing the pandemic of HSV-2 infections4,14, with HSV-2 be-
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ing the most common cause of genital ulcers not only in
the developed world but also in many developing coun-
tries as well15–17. Although the HSV-2 infection is one of
the most common sexually transmitted diseases world-
wide18–21 and despite the fact, that according to the re-
ports from the gynaecologists in the field who notice that
occurrence of this infection is constantly increasing in
Croatia22, during the past twenty years there has not
been any epidemiological report concerning the seropre-
valence of HSV-2 in the Croatian population22,23. In the
European epidemiological studies, blood donors are often
used to represent the general population since all Euro-
pean countries have unpaid donors24 and in performing
present study we also follow such presumption. The aim
of this study was to establish the seroprevalence of her-
pes simplex virus type 2 (HSV-2) among sexually active
adults from East Croatia and to evaluate its correlates
with demographic and behavioural risk factors.
Subjects and Methods
This cross-sectional study was conducted from the 1st
June 1 until 30th September 2005 at the Department of
Transfusion Medicine, Osijek University Hospital Cen-
ter. The study was approved by the Ethics Committee for
Medical Research of the Medical School Osijek and the
written informed consent has been obtained from each
subject.
Subjects
The study initially included 440 blood donors of both
sexes (of a total of 4000 blood donors registered in East
Croatia). Study subjects were randomly selected among
blood donors aged 20–59. Out of 440 initially selected
blood donors, 427 gave their consent to take part in the
study (response rate, 97%) preceded by thorough verbal
and written information on the methodology and the
purpose of the study.
Besides 450-mL blood unit collected, an additional
5-mL blood sample was obtained from each blood donor
for serologic testing. The donors were also asked to fill-in
the anonymous questionnaire on their sexual behaviour
that may have implied their HSV-2 exposure. Blood sam-
pling for study testing was performed after blood dona-
tion, from the same site as venepuncture for blood dona-
tion to obviate unnecessary vein puncture. Upon collec-
tion, the blood samples were transported to the Depart-
ment of Microbiology, Public Health Institute of the
Osijek-Baranja County, where serum was prepared by
the whole blood centrifugation and stored at –20C until
the analysis.
Four of 427 subjects reported that they had never
been sexually active and were then excluded from the
study as being incompatible with the study aim and hy-
pothesis as well as because of literature data confirming
the HSV-2 seroprevalence being negligible in individuals
that have never been sexually active11,25. The rest of 423
subjects that reported sexual activity were included in
further laboratory and statistical analysis.
Anonymous questionnaire
Study subjects were asked to fill-in an anonymous
questionnaire in order to identify different demographic
and behavioural risk factors that may have implied their
exposure to HSV-2. There were 15 questions, 13 of them
of closed type (with optional answers to be marked) and
two of open type (the year of the birth and the age at the
first sexual contact). Demographic data included the
place of residence, age, sex, level of education, and mari-
tal status. Data on sexual preferences included questions
of sexual activity during the lifetime, the age at the first
sexual contact, partner sex, receiving or giving payment
for sex during the lifetime, the type of sexual activities
during the lifetime, the regularity of condoms usage dur-
ing the sexual contacts with new partners, lifetime his-
tory of sexually transmitted diseases (STDs), number of
sexual partners during the lifetime, sexual activity and
the number of sexual partners in the past year. The ques-
tionnaire employed as a research tool in the present
study was previously validated in a small group of blood
donors in 2004. The questionnaire used in this study was
presented in details in Table 1.
Laboratory analysis
The blood samples collected, i.e. whole blood sera,
were analysed by use of the commercial anti-HSV-2 ELISA
(IgG) test kit (EUROIMMUN Medizinische Labordiag-
nostika AG, Lübeck, Germany), strictly according to the
manufacturer’s instructions26. This assay identifies IgG
antibodies to G2 glycoprotein, considered as the only reli-
able marker of HSV-2 infection, while detection of anti-
bodies to HSV-2 G2 glycoprotein is considered to reliably
demonstrate the subject’s contact with this virus ty-
pe19–21. All ELISA positive and ELISA equivocal blood
samples were additionally tested with the anti-HSV-2
gG-2 EUROLINE-WB (IgG) Western blot test kit (EU-
ROIMMUN Medizinische Labordiagnostika AG, Lübeck,
Germany), strictly following the manufacturer’s instruc-
tions27. Upon confirmation testing, all blood samples
were classified as definitely positive or definitely nega-
tive, and then submitted to statistical processing.
Statistics
Descriptive statistics were used for data processing
and analysed using SPSS Statistical Package for Win-
dows, version 13.0 (SPSS Inc., Chicago, IL, USA). Nor-
mality of data distribution was tested with the Kolmo-
gorov-Smirnov test; the c2-test and the Fisher exact test
were used to determine differences in the distribution of
qualitative variables. On all statistical analyses, two-
-sided p-values of 0.05 and lesser ones were considered
significant.
Results
The final study sample of 423 sexually active donors
from East Croatia consisted of 366/423 (86.5%) male and
57/423 (13.5%) female subjects, mean age 34.6±10.5
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(range 20.0–57.0) years. According to the place of resi-
dence, 283/423 (66.9%) subjects were from the urban set-
ting and 140/423 (33.1%) from the rural setting. There
were 323/423 (76.4%) subjects with high school educa-
tion, 68/423 (16.0%) with finished university, and 32/423
(7.6%) had lower than high school education. According
to marital status, there were 233/423 (55.1%) married
and 190/423 (44.9%) single subjects.
According to the sexual orientation there were 421/
423 (95.5%) heterosexual subjects and 2/423 (0.5%) ho-
mosexual or bisexual subjects. Among all the study sub-
jects there were 15/423 (3.5%) of them who reported re-
ceiving or giving payment for the sex during the lifetime.
According to the practiced types of sexual intercourses
there were 219/423 (51.8%) study subjects who reported
practicing solely vaginal type of sexual intercourse and
204/423 (48.2%) study subjects who reported practicing
different types of sexual intercourses. Irregular condom
use with new sexual partners during the lifetime was re-
ported by 204/423 (48.2%) of all the study subjects.
Among all the study subjects there were 19/423 (4.5%) of
them who had been diagnosed with any kind of STD at
least once during the lifetime. According to their answers
in anonymous questionnaires among all the study sub-
jects there were 213/423 (50.4%) of them who had five or
more sexual partners during lifetime and 106/423
(25.1%) of them who had two or more sexual partners
during the one year that precede this study.
The Western blot testing of donor blood revealed 14
(3.3%) of 423 blood samples to be positive for the pres-
ence of HSV-2 IgG antibodies, including 10/366 (2.7%)
male and 4/57 (7.0%) female donors. Sex difference in the
positivity for HSV-2 IgG antibodies was not statistically
significant (Fisher exact test=2.830; p=0.0925) (Figure
1).
Since age is an important determinant of sexual be-
haviour28,29, study subjects were divided into two age
groups: the younger group, aged 20–39 (n=285) and the
older group, aged 40–59 (n=138) years regarding all the
analysis of HSV-2 IgG findings. Findings positive for
HSV-2 IgG antibodies were recorded in 6/285 (2.1%) sub-
jects from the younger group and 8/138 (5.8%) subjects
from the older group. Difference in the rate of findings
positive for HSV-2 IgG antibodies between the two age
groups was statistically significant (Fisher exact test
=3.960; p=0.0465) (Figure 2). According to the marital
status HSV-2 IgG antibody positivity was determined in
3.0% (7/233) married subjects and 3.7% (7/190) single
subjects but this difference was not statistically signifi-
cant (Fisher exact test=0.151; p=0.6974). Considering
the prevalence of the behavioural risk factors for HSV-2
infection in HSV-2 IgG positive and negative subjects,




























Fig. 1. Blood donors from East Croatia positive and negative for
HSV-2 IgG antibodies according to the sex.
TABLE 1
ANONYMOUS QUESTIONNAIRE FOR BLOOD DONORS – STUDY
SUBJECTS IN THE STUDY ABOUT THE HERPES SIMPLEX
VIRUS TYPE 2
Please circle or write your answer!
1. Place of residence: a) urban setting b) rural setting
2. The year of birth:
3. Sex: Male Female
4. Level of education:
a) unfinished elementary school
b) finished elementary school





b) single (never married)
c) divorced / widowed
6. Have you ever, during lifetime, been sexually active: YES
NO
7. Age at first intercourse:
8. Sexual orientation: a) heterosexual b) homosexual c) bi-
sexual
9. Have you ever, during the lifetime, paid for or being paid
for sexual services: YES NO
10. Type of sexual intercourses that you have been practicing
during the lifetime:
a) I have never been sexually active
b) Solely vaginal type of sexual intercourse
c) Mostly vaginal and besides them sometimes anal
and/or oral type of sexual intercourse
d) Solely anal type of sexual intercourse
e) Solely oral type of sexual intercourse
11. During the sexual intercourses with new partners during
the lifetime I have always used condoms: YES NO
12. How often, during the lifetime, have you been diagnosed
with any type of sexually transmitted disease: a) never (0
times) b) once (1 time) c) 2 or more times
13. Number of sexual partners during the lifetime:
a) 0 b) 1 c) 2–4 d) 5–9 e) 10–19 f) 20 or more
14. Have you been sexually active during the last year: YES
NO
15. Number of sexual partners during the last year:
a) 0 b) 1 c) 2 d) 3 or more
Thank you very much for your cooperation!
only the irregular condom use on sexual intercourses
with new partners and higher number (five or more) of
sexual partners during lifetime were connected with the
HSV-2 IgG antibody positivity, but none of those were
statistically significant (Fisher exact test=0.562; p=0.4535
and c2=2.572; p=0.1088, respectively).
Among the younger and the older groups of blood do-
nors there were differences in the prevalence of the vari-
ous types of behavioural risk factors for HSV-2 infection.
In the younger group of the blood donors there were
2/285 (0.7%) homosexual and bisexual oriented blood do-
nors, while in the older group of the blood donors all of
them were heterosexual. Within the younger group of
the blood donors there was a larger proportion of the
blood donors who received or gave payment for sex dur-
ing the lifetime, who practiced different types of sexual
intercourses, and who had two or more sexual partners
during the year that precede this study than in the older
group of the blood donors with the last two differences
being statistically significant (c2=14.823, p<0.0001; c2=
5.258, p=0.0218). Within the older group of the blood do-
nors there was a larger proportion of them who had one
or more STDs during the lifetime, who had five or more
sexual partners during the lifetime, and who reported
the irregular condom use with new sexual partners dur-
ing the lifetime than in the younger group of the blood
donors with the last difference being statistically signifi-
cant (c2=5.161, p=0.0231) (Table 2).
Discussion and Conclusion
The present study that included blood donors from
East Croatia was the first study specifically investigating
HSV-2 seroprevalence in the general Croatian popula-
tion. Following the customary practice in majority of Eu-
ropean epidemiological studies we presumed that the
blood donors were representative for the general po-
pulation24. Using the Western blot analysis, the presence
of HSV-2 IgG antibodies was recorded in 3.3% (14/423) of
donor blood samples, as a reliable indicator of their pre-
vious contact with HSV-219–21.
The Western blot testing of donor blood samples from
other European countries (Poland, Italy, Norway, Ger-
many, and United Kingdom) showed the seroprevalence
of HSV-2 in blood donors from these countries to range
from 5.0% to 11.0%. These values are comparable to Croa-
tian samples despite the fact that seroprevalence of HSV-
-2 in Croatian blood donors was a little bit lower3,4,12,30.
As the variations in HSV-2 seroprevalence resulted from
different levels of HSV-2 dissemination in the popula-
tions of the respective countries12,17, it can be concluded
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TABLE 2






Younger group Older group
Receiving or giving payment
for sex during the lifetime
Yes 13 (4.6%) 2 (1.4%) Fisher exact
test=2.633;
p=0.1047
No 272 (95.4%) 136 (98.6%)
Types of sexual intercourses
during the lifetime
Different types 156 (54.7%) 48 (34.8%) c2=14.823;
p<0.0001*Only vaginal 129 (45.3%) 90 (65.2%)
Irregular condom use with new
sexual partners during the lifetime
Yes 188 (66.0%) 106 (76.8%) c2=5.161;
p=0.0231*No 97 (34.0%) 32 (23.2%)
Number of STDs during
the lifetime
1 or more 12 (4.2%) 7 (5.1%) Fisher exact
test=0.161;
p=0.6882
0 273 (95.8%) 131 (94.9%)
Number of sexual partners
during the lifetime
5 or more 138 (48.4%) 75 (54.3%) c2=1.306;
p=0.25301–4 147 (51.6%) 63 (45.7%)
Number of sexual partners during
the year that precede this study
2 or more 81 (28.4%) 25 (18.1%) c2=5.258;
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Fig. 2. Blood donors from East Croatia positive and negative for
HSV-2 IgG antibodies according to the age groups.
that the prevalence of HSV-2 in the general population of
Croatia is lower in comparison with the industrialized
countries of Western and Northern Europe.
In the present study, higher HSV-2 seroprevalence
was associated with female sex, older age, marital status
(with single subjects been under the greater risk), irregu-
lar condom usage during the sexual intercourses with
new partners and with higher number (five or more) of
sexual partners during lifetime and these findings are
consistent with the findings of other similar surveys31–34.
The fact that the female sex is a risk factor for HSV-2
infection is explained by the more efficient male to fe-
male transmission than female to male transmission6,35
of this virus and by the anatomic features of the female
genital10. Concerning this, it has been emphasized that
besides the exposure of a larger genital surface in wo-
men, female mucosa and genital skin is more susceptible
to herpes simplex viruses’ type 1 or type 2 than the
penile epithelium10.
Among other risk factors some studies pointed to the
older age as a risk factor (with persons of 35 and more
years being under the greater risk)7,32–34. It is believed
that the age is closely connected with another risk factor,
the duration of sexual activity, where, obviously, larger
number of years of sexual activity represents greater
risk2,34,36.
Although some studies had pointed out to the connec-
tion between lower education, early age of first sexual in-
tercourse (younger than 17 years), homosexual and bi-
sexual orientation, prostitution, practice of anal sexual
intercourses, history of sexually transmitted diseases
and larger number of sexual partners during the one
year prior to the investigation of HSV-2 seroprevalence
in a population and ones HSV-2 positivity13,25,36 our study
did not confirm these connections.
Comparisons between the younger and the older
group of the blood donors had detected differences in
proportions of various behavioural risk factors for HSV-2
infection. In that sense it is especially interesting to em-
phasize that although the blood donors from the younger
group had more frequently involved themselves in the
various types of the risky sexual behaviour they had also
more frequently used condoms for protection. These data
are consistent with the results reported from the other
studies conducted among the Croatian youth, which had
showed the rate of condom usage to be higher among the
younger individuals who generally have a greater num-
ber of sexual partners37–39. In this way, by the frequent
use of condoms as a method of protection, young people
tend to neutralize the effect and prevent the occurrence
of the detrimental consequences (primarily HIV infec-
tion) of their more liberal attitude towards promiscuous
relations37,40.
The first limitation of the present study is very low
overall number of positive subjects. Because of that we
probably failed to succeed in our attempt to confirm the
association between HSV-2 positivity and lower educa-
tional status, early onset of sexual activity (before the
age of 17) and practice of anal sexual intercourses that
had been shown in some other studies22. The second limi-
tation of this study results from the features of the sex-
ual behaviour of blood donors. Despite the fact that blood
donors are representative for the general population one
can still say that this population is in fact the low risk
population concerning the sexual behaviour12,17,22 (in which
some forms of risky sexual behaviour such as homosex-
ual and/or bisexual orientation, prostitution, history of
sexually transmitted diseases and large number of sexual
partners during the one year prior to the enrolment in
the HSV-2 seroprevalence investigation are quite rear)
and because of that the present study did not show the
connection between HSV-2 positivity and some of the
above mentioned forms of risky sexual behaviour22.
Finding that among blood donors there are also
HSV-2 positive individuals confirms the fact that genital
herpes is one of the most common sexually transmitted
disease worldwide1,5,20,21 which public health significance
is constantly growing18,29,41. Concerning this, one must
bear on mind that fight against the viral sexually trans-
mitted diseases (such as HSV-2 infections but also HIV
disease) cannot be effective if directed only towards high
risk groups22,42, but must also include preventive actions
in low risk groups (such as blood donors), because only
that comprehensive approach truly protects the whole
population22,43.
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PREVALENCIJA I RIZI^NI ^IMBENICI ZA NASTANAK INFEKCIJA VIRUSOM HERPES SIMPLEX
TIP 2 U ISTO^NOJ HRVATSKOJ
S A @ E T A K
Cilj ovoga istra`ivanja bio je utvrditi seroprevalenciju virusa herpes simplex tipa 2 (HSV-2) me|u spolno aktivnim
odraslim osobama s podru~ja isto~ne Hrvatske, te procijeniti njezinu povezanost s demografskim osobinama, te ri-
zi~nim oblicima spolnog pona{anja ispitanika. Ova cross-sectional studija provedena je u razdoblju od 1. lipnja do 30.
rujna 2005. godine na Odjelu za transfuzijsku medicinu Klini~kog bolni~kog centra Osijek. Istra`ivanje je uklju~ilo 423
dobrovoljnih davatelja krvi (DDK) od kojih je bilo 366 (86,5%) mu{karaca i 57 (13,5%) `ena. Demografski podatci o
ispitanicima, te podatci o njihovom spolno rizi~nom pona{anju tijekom `ivota dobiveni su s pomo}u anonimnog an-
ketnog upitnika koji se sastojao od 15 pitanja. Western blot testiranjem krvi DDK na prisustvo protutijela klase IgG na
herpes simplex virus tipa 2 utvr|eno je kako su uzorci krvi 14 (3,3%) dobrovoljnih davatelja bili pozitivni na prisutnost
protutijela klase IgG na herpes simplex virus tipa 2, pri ~emu je pozitivnost utvr|ena u 10 (2,7%) mu{karaca te 4 (7,0%)
`ene. Vi{a seroprevalencija HSV-2 bila je povezana sa `enskim spolom, starijom dobi, bra~nim statusom (pri ~emu su
samci imali ve}i rizik), neredovitom uporabom kondoma s novim spolnim partnerima tijekom `ivota, te s ve}im brojem
(pet ili vi{e) spolnih partnera tijekom `ivota. Me|u utvr|enim rizi~nim ~imbenicima za nastanak infekcije virusom
HSV-2 u promatranoj populaciji jedino je povezanost izme|u starije dobi ispitanika te pozitivnosti na HSV-2 bila sta-
tisti~ki zna~ajna. U promatranoj populaciji, demografske osobine ispitanika su zna~ajnije povezane s vi{om prevalen-
cijom HSV-2 nego li njihovo rizi~no spolno pona{anje.
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